Alterations in apoptotic signaling in human idiopathic cardiomyopathic hearts in failure

Charles Steenbergen1, Cynthia A Afshari, John G Petranka

  • 1Department of Pathology, Duke University Medical Center, Durham 27710, USA.

Insights

This study investigated gene expression in human hearts with dilated cardiomyopathy and heart failure. Researchers found a shift towards apoptosis, with decreased expression of key anti-apoptotic genes, suggesting new therapeutic targets.

Area of Science:

  • Cardiovascular Biology
  • Molecular Medicine
  • Genomics

Background:

  • Dilated cardiomyopathy (DCM) is a heart failure cause with unknown origins.
  • Altered gene expression is implicated in heart failure progression, but human data is limited.
  • Apoptosis plays a role in heart failure pathogenesis.

Purpose of the Study:

  • To investigate changes in apoptosis-related gene expression in human idiopathic DCM hearts with heart failure.
  • To identify specific molecular pathways altered in human heart failure.
  • To uncover potential therapeutic targets for DCM and heart failure.

Main Methods:

  • DNA microarray profiling of human idiopathic dilated cardiomyopathic hearts.
  • Analysis of gene expression changes related to apoptosis.
  • Investigation of the Tumor Necrosis Factor-alpha (TNF-alpha) signaling pathway.

Main Results:

  • Observed a proapoptotic shift in the TNF-alpha signaling pathway.
  • Found decreased expression of TNF-alpha- and Nuclear Factor-kappaB (NF-kappaB)-induced antiapoptotic genes, including growth arrest and DNA damage-inducible beta (GADD45beta), Flice inhibitory protein (FLIP), and TNF-induced protein 3 (A20).
  • Observed decreased phosphorylation of BAD at Ser-112, consistent with increased apoptosis.

Conclusions:

  • Human heart failure associated with DCM exhibits altered gene expression favoring apoptosis.
  • The TNF-alpha signaling pathway is significantly impacted in failing human hearts.
  • Identified specific genes and pathways as potential therapeutic targets for heart failure treatment.

Related Concept Videos

Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Myocarditis I: Introduction01:21

Myocarditis I: Introduction

Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...